AI assistant
Emcure Pharmaceuticals Limited — Call Transcript 2024
Aug 14, 2024
60464_rns_2024-08-14_efab0ef9-0e6e-4ba5-bdf4-0940ebee6d6b.pdf
Call Transcript
Open in viewerOpens in your device viewer
Emcure
Ref: EPL/CS/SE/0010/2024
Date: August 14, 2024
To,
National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE
Dear Sir/Madam,
Subject: Audio recording of Earnings Call - Q1 FY25
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated August 8, 2024 regarding earnings call, the audio recording of the call held today is available on our website. The said audio recording can be accessed through the below web address:
https://www.emcure.com/wp-content/uploads/2024/08/Audio-recording-of-Earning-call-Q1-FY-25_14.08.2024.mp3
You are requested to take the above information on your records.
Thanking you,
For Emcure Pharmaceuticals Limited
SHARMA Digitally signed by SHARMA CHETAN CHETAN RAJENDRA Date: 2024.08.14 RAJENDRA 14:58:34 +05'30'
Chetan Sharma Company Secretary & Compliance Officer
Emcure Pharmaceuticals Limited
Registered Office : Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: [email protected] Website: www.emcure.com CIN: U24231PN1981PLC024251